DUBLIN–(BUSINESS WIRE)–The “Biomedical and ICT Convergence Market by Technology, Solution and Region 2025-2030” report has been added to ResearchAndMarkets.com’s providing.
This report evaluates the market for convergence between the Information and Communications Technology (ICT) business and biomedical science and applied sciences. The report evaluates the latter and analyzes the previous when it comes to ICT innovation comparable to linked medical units. In addition to forecasts for IoT linked healthcare units (standalone, wearable, and implantable), the report additionally assesses the outlook for varied biomedical merchandise, companies, and options poised to profit from varied IT and telecom applied sciences.
The subject of biomedicine represents a classy intersection of varied pure science disciplines, together with biology, chemistry, and physics, synthesized to advance our understanding of human well being. It is basically devoted to the creation of modern interventions, therapeutic modalities, and medical applied sciences that improve medical observe.
Parallel to this, the Information and Communications Technology (ICT) sector encompasses the huge infrastructure of telecommunications and computing, specializing in the seamless integration of {hardware} and software program to handle knowledge. This sector is usually categorized inside the broader TMT framework – Technology, Media, and Telecommunications, which accounts for the convergence of digital programs, broadcast media, and knowledge transmission. Together, these industries kind the spine of recent digital commerce, content material distribution, and interactive purposes.
The deliberate convergence of biomedical science and ICT signifies a monumental shift for each the healthcare and know-how industries, making a excessive-development space characterised by cross-disciplinary innovation. Beyond the standard aims of eradicating illnesses and stopping persistent illnesses, the wedding of those fields is designed to improve the precision of medical remedies.
By leveraging digital instruments, suppliers can enhance the general efficacy of care whereas streamlining the logistics of healthcare supply. This synergy ensures that medical companies usually are not solely simpler but additionally extra accessible and systematically organized, remodeling the affected person expertise from a fragmented course of right into a cohesive, knowledge-pushed journey.
Addressing the financial challenges of recent medication is probably essentially the most pressing driver of this technological integration. Healthcare expenditures constantly outpace basic inflation, threatening the sustainability of world well being programs. Consequently, there’s a important want to enhance affected person outcomes whereas concurrently lowering the monetary burden of care.
This includes optimizing operational expenditures and mitigating the immense prices related to analysis and improvement. In areas like pharmaceutical drug discovery and vaccine improvement, the applying of precision medication, which tailors therapy to particular person genetic profiles, is important for lowering the wasted sources usually present in “one-size-fits-all” medical fashions.
The sensible software of ICT in medical settings usually manifests by the Internet of Things (IoT), the place enabled units monitor affected person responses to varied procedures in actual time. Such granular monitoring is important when introducing new or unproven healthcare modalities.
A pertinent instance includes vaccine administration and the rising examine of epigenetics, which examines how environmental elements and behaviors affect gene expression with out altering the underlying DNA sequence. While a medical intervention like a vaccine is designed with the singular, constructive intent of illness inoculation, ICT instruments may also help determine the minute subset of the inhabitants which may expertise unintended physiological penalties due to their distinctive epigenetic markers.
One of essentially the most dynamic subsectors of this convergence is the proliferation of wi-fi, IP-enabled handheld units and wearable applied sciences. These instruments, alongside refined implantable sensors, provide a degree of steady physiological monitoring that was beforehand inconceivable within the historical past of medical science.
These linked units function complete platforms for medical determination assist and automated therapy administration. By offering clinicians with a relentless stream of excessive-constancy knowledge, these applied sciences enable for extra knowledgeable diagnoses and extra fast changes to therapy plans.
Ultimately, these digital instruments are equally efficient throughout each reactive and proactive medical frameworks. In reactive care, they will handle persistent circumstances like diabetes by automated insulin modification; in proactive care, they will optimize vaccine schedules and formulations to forestall sickness earlier than it happens.
The integration of ICT and biomedicine is due to this fact anticipated to yield a twin profit: it should stabilize the economics of healthcare by decreasing prices and uncovering new income streams by novel remedies, whereas concurrently elevating the requirements of world public well being by customized, knowledge-centric care.
Key Topics Covered:
1. Executive Summary
1.1 Overview
1.2 Research Objectives
1.3 Select Findings
2. Introduction
2.1 Biomedical Technology
2.1.1 Biomedical Science
2.1.2 Biomedical Engineering
2.1.3 Biomedical Informatics
2.1.4 Biomedical Research and Development
2.2 Biomedical and ICT Convergence
2.3 Biotechnology vs. Biomedical Technology
2.4 Biomedicine
2.5 Market Trends
3. Biomedical and ICT Technologies and Solutions
3.1 Technology Analysis
3.1.1 Biomedical Diagnostics Devices
3.1.1.1 Electrochemical Test Strips
3.1.1.2 Integrated Cartridges
3.1.1.3 Lateral Flow Assays
3.1.1.4 Molecular Diagnostics
3.1.2 Bionanotechnology
3.1.3 Temperature Sensors
3.1.4 Refrigerators and Freezers
3.1.5 Metal Equipment
3.1.6 Software Technology and ICT Services
3.2 Biomedical and ICT Application Analysis
3.2.1 Diagnostics and Research Solution
3.2.2 Tissue Engineering and Regeneration
3.2.3 Fermentation
3.2.4 Cell Based Assay
3.2.5 PCR Technology
3.2.6 Chromatography
3.2.7 Additive Metal Solution
3.3 Cloning and Somatic Cell Nuclear Transfer
3.4 Industry Specific Uses
3.4.1 Medical, Pharmaceutical, and Health
3.4.2 Food and Agriculture
3.4.3 Natural Resources and Environment
3.4.4 Industrial Processing
3.4.5 Bioinformatics
3.5 Cloud Deployment and IT Infrastructure Management
4. Company Analysis
4.1 Abbott Laboratories
4.2 Amgen Inc.
4.3 Analog Devices
4.4 AstraZeneca
4.5 Biogen
4.6 Bio Rad Laboratories
4.7 Biodirection (NanoDX)
4.8 BioTelemetry (Philips Company)
4.9 Carpenter Technology (CRS Holdings)
4.10 Celgene Corporation
4.11 Dentsply Sirona
4.12 First Sensor
4.13 GE Healthcare
4.14 Gilead Sciences
4.15 Haier Biomedical
4.16 Helmer Scientific
4.17 Hoffman-La Roche Ltd.
4.18 Honeywell
4.19 Johnson & Johnson Services
4.20 Lonza Group
4.21 Medtronic
4.22 Merck & Co
4.23 Nonin Medical
4.24 Novartis AG
4.25 Novo Nordisk
4.26 NXP Semiconductor
4.27 Panasonic
4.28 Pfizer Inc.
4.29 Sanofi Aventis
4.30 Smiths Medical Inc.
4.31 STMicroelectronics
4.32 TE Connectivity
4.33 Texas Instruments
4.34 Thermo Fisher
4.35 Wright Medical Group
4.36 Zimmer Biomet
4.37 Lifesense Group B.V.
4.38 ActiveLinxx LLC
4.39 Samsung Healthcare
4.40 Agfa Healthcare
4.41 Drager
4.42 Fresenius Medical Care
4.43 KLS Martin Group
4.44 Getinge AB
4.45 Olympus Corporation
4.46 Philips Healthcare
4.47 Siemens Healthineers
4.48 Skanray Technologies
4.49 Stryker
4.50 Jafron Biomedical Co Ltd
5. Market Analysis and Forecast 2025-2030
5.1 Global Biomedical ICT Market 2025-2030
5.1.1 Global Biomedical ICT Market
5.1.2 Biomedical ICT Market by Technology
5.1.3 Biomedical ICT Market by Solution
5.1.4 Biomedical ICT Market by Industry Vertical
5.1.5 Biomedical ICT Market by Cloud Deployment
5.2 Regional Biomedical ICT Market 2025-2030: Hardware, Software, Service, Solution, Industry Vertical, Cloud Deployment, and Country
6. Conclusions and Recommendations
6.1 Advertisers and Media Companies
6.2 Artificial Intelligence Providers
6.3 Biomedical Device and Equipment Providers
6.4 Broadband Infrastructure Providers
6.5 Communication Service Providers
6.6 Computing Companies
6.7 Data Analytics Providers
6.8 Contract Research Organizations
6.9 Networking Equipment Providers
6.10 Networking Security Providers
6.11 Semiconductor Companies
6.12 IoT Suppliers and Service Providers
6.13 Software Providers
6.14 Pharmaceuticals and Hospitals
6.15 Enterprise and Government
6.16 Recommendations for Biomedical Investors
7. Appendix: Connected Medical Device Market Analysis and Forecasts 2025-2030
7.1 Connected Medical Device Market Drivers
7.1.1 Connected Health and Telemedicine
7.1.2 Wearable Healthcare Devices
7.1.3 Specialized Healthcare Devices
7.2 Global Connected Medical Device Market
7.3 Connected Medical Device Market by Manufacturing Method
7.4 Connected Medical Device Market by Location/ Usage
7.5 Connected Medical Device Market by Delivery/Acquisition
7.6 Connected Medical Device Market by Risk Classification
7.7 Connected Medical Device Market by Industry Sub-sector
7.8 Connected Medical Device Market by Key Therapeutic Segments
7.9 Connected Medical Device Market by Connectivity Method
7.10 Connected Medical Device Markets by Region
For extra details about this report go to https://www.researchandmarkets.com/r/9ao903
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis studies and market knowledge. We give you the newest knowledge on worldwide and regional markets, key industries, the highest firms, new merchandise and the newest tendencies.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900